These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 30797231)

  • 41. Contrast-Enhanced Ultrasound Biopsy of Sentinel Lymph Nodes in Patients with Breast Cancer: Implications for Axillary Metastases and Conservation.
    Cox K; Weeks J; Mills P; Chalmers R; Devalia H; Fish D; Sever A
    Ann Surg Oncol; 2016 Jan; 23(1):58-64. PubMed ID: 25990967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paradigm shift in axilla surgery for breast cancer patients treated with sentinel node biopsy.
    Imoto S; Isaka H; Sakemura N; Ito H; Imi K; Miyamoto K
    Breast Cancer; 2012 Apr; 19(2):104-9. PubMed ID: 22038672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.
    Espinosa-Bravo M; Sansano I; Pérez-Hoyos S; Ramos M; Sancho M; Xercavins J; Rubio IT; Peg V
    Eur J Surg Oncol; 2013 Jul; 39(7):766-73. PubMed ID: 23607911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer.
    Yao MS; Kurland BF; Smith AH; Schubert EK; Dunnwald LK; Byrd DR; Mankoff DA
    Ann Surg Oncol; 2007 Oct; 14(10):2985-93. PubMed ID: 17564747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of a Rare Earth Nanoprobe Enables In Vivo Real-Time Detection of Sentinel Lymph Node Metastasis of Breast Cancer Using NIR-IIb Imaging.
    Zhu YY; Song L; Zhang YQ; Liu WL; Chen WL; Gao WL; Zhang LX; Wang JZ; Ming ZH; Zhang Y; Zhang GJ
    Cancer Res; 2023 Oct; 83(20):3428-3441. PubMed ID: 37540231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
    Stafford AP; Hoskin TL; Day CN; Sanders SB; Boughey JC
    Ann Surg Oncol; 2022 Aug; 29(8):4740-4749. PubMed ID: 35451727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical implication in patients with cervical cancer: Subgroup analysis of the SCCAN project.
    Dostálek L; Benešová K; Klát J; Kim SH; Falconer H; Kostun J; Dos Reis R; Zapardiel I; Landoni F; Ortiz DI; van Lonkhuijzen LRCW; Lopez A; Odetto D; Borčinová M; Jarkovsky J; Salehi S; Němejcová K; Bajsová S; Park KJ; Javůrková V; Abu-Rustum NR; Dundr P; Cibula D
    Gynecol Oncol; 2023 Jan; 168():151-156. PubMed ID: 36442426
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.
    Pugliese MS; Beatty JD; Tickman RJ; Allison KH; Atwood MK; Szymonifka J; Arthurs ZM; Huynh PP; Dawson JH
    Ann Surg Oncol; 2009 Jan; 16(1):113-20. PubMed ID: 18949520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
    Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Macrometastasis, micrometastasis, and isolated tumor cells in sentinel lymph nodes of early breast cancers: a 10-year histopathological and survival analysis of 537 Asian patients.
    Co M; Kwong A
    World J Surg; 2015 Jun; 39(6):1438-42. PubMed ID: 25651960
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Added value of repeat sentinel lymph node biopsy in FDG-PET/CT node-negative patients with ipsilateral breast cancer recurrence.
    Haarsma R; van Loevezijn AA; Donswijk ML; Scholten AN; Vrancken Peeters MTFD; van Duijnhoven FH
    Breast Cancer Res Treat; 2022 Aug; 194(3):617-627. PubMed ID: 35727380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is Axillary Lymph Node Dissection Necessary After a Positive Sentinel Lymph Node Biopsy?
    Ozcan LC; Giuliano AE
    Adv Surg; 2017 Sep; 51(1):165-178. PubMed ID: 28797338
    [No Abstract]   [Full Text] [Related]  

  • 54. Breast cancer larger than 2.5 cm with tumor-free radioisotope-hot sentinel nodes has higher risk of non-hot axillary lymph node metastasis.
    Liu YL; Kuo WL; Lo YF; Tsai HP; Shen SC; Yu CC; Chou HH; Chu CH; Chen SC
    Biomed J; 2022 Apr; 45(2):396-405. PubMed ID: 35562283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
    Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
    Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer?
    Magnoni F; Corso G; Gilardi L; Pagan E; Massari G; Girardi A; Ghidinelli F; Bagnardi V; Galimberti V; Grana CM; Veronesi P
    Future Oncol; 2022 Jan; 18(2):193-204. PubMed ID: 34882010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The significance of sentinel lymph node micrometastasis in breast cancer: Comparing outcomes with and without axillary clearance.
    Youssef MMG; Cameron D; Pucher PH; Olsen S; Ferguson D
    Breast; 2016 Dec; 30():101-104. PubMed ID: 27668857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection.
    Fournier K; Schiller A; Perry RR; Laronga C
    Ann Surg; 2004 Jun; 239(6):859-63; discussion 863-5. PubMed ID: 15166965
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrence rates in breast cancer patients with false-negative intraoperative evaluation of sentinel lymph nodes.
    Taras AR; Hendrickson NA; Lowe KA; Atwood M; Beatty JD
    Am J Surg; 2010 May; 199(5):625-8. PubMed ID: 20466106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.